Dual Immunocytochemical Analysis of Oestrogen and Epidermal Growth Factor Receptors in Breast Cancer
Author Information
Author(s): A.K. Sharma, K. Horgan, A. Douglas-Jones, R. McClelland, J. Gee, R. Nicholson
Primary Institution: University of Wales College of Medicine
Hypothesis
The study investigates the relationship between oestrogen receptor (ER) and epidermal growth factor receptor (EGFR) levels in human breast cancer.
Conclusion
The results suggest that ER and EGFR expression are mutually exclusive within individual breast cancer cells.
Supporting Evidence
- All 22 samples exhibited ER positivity with a mean of 49%.
- EGFR positivity ranged from 2% to 70% with a mean of 21%.
- Significant correlations were found between single and dual assays for both ER and EGFR.
Takeaway
This study looked at breast cancer cells to see how two important receptors, ER and EGFR, work together, and found that they don't mix in the same cell.
Methodology
The study used a dual immunocytochemical assay to stain for both ER and EGFR on single frozen sections of breast cancer tissue.
Limitations
The study involved a small sample size and may not represent all breast cancer cases.
Participant Demographics
Participants were female breast cancer patients aged 35-81, with 9 premenopausal and 13 postmenopausal.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website